Skip to main navigation Skip to search Skip to main content

Blinatumomab nonresponse correlates with poor survival after brexucabtagene autoleucel in B-cell ALL

  • Hrishikesh K. Srinagesh
  • , Vishal Gupta
  • , Amy Zhang
  • , Michael Grunwald
  • , Matthew Connor
  • , Vamsi K. Kota
  • , Jacob Boccucci
  • , Matthew Ulrickson
  • , Roshini Pradeep
  • , La Quisa Hill
  • , Stephanie B. Tsai
  • , Timothy O'Connor
  • , Karamjeet Sandhu
  • , Anjali S. Advani
  • , Ran Reshef
  • , Christian A. Gordillo
  • , Marlise R. Luskin
  • , Evan C. Chen
  • , Chenyu Lin
  • , Ryan D. Cassaday
  • Noam E. Kopmar, Navneet S. Majhail, Minoo Battiwalla, Stephen A. Strickland, Catherine J. Lee, Silvina Odstrcil Bobillo, Talal Hilal, Jae H. Park, Yannis K. Valtis, Rawan Faramand, Melhem M. Solh, Caitlin Guzowski, Sumithira Vasu, Jessica T. Leonard, Virginia Tan, Eunice S. Wang, Ross McCauley, Joshua Sasine, Kevin Tang, Katharine Miller, Katherine C. Sutherland, Michael Daunov, Razan Mohty, Omer Jamy, Muthu V. Kumaran, Rasmus T. Hoeg, Kaitlyn C. Dykes, Aaron C. Logan, Tamer Othman, Wendy Stock, Marc Schwartz, Kenneth Byrd, Fevzi Yalniz, Veronika Bachanova, Sean Tracy, George Yaghmour, Vivian M. Irizarry Gatell, Clayton W. Jackson, Olalekan O. Oluwole, Bhagirathbhai Dholaria, Kristen M. O'Dwyer, Jozal Moore, Gregory W. Roloff, Noelle V. Frey, Ibrahim Aldoss, Bijal D. Shah, Caspian H. Oliai, Lori S. Muffly

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Blinatumomab nonresponse correlates with poor survival after brexucabtagene autoleucel in B-cell ALL'. Together they form a unique fingerprint.
Sort by

Keyphrases

Biochemistry, Genetics and Molecular Biology

Nursing and Health Professions

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science